Breaking News, Collaborations & Alliances

DisperSol, Catalent Enter Manufacturing Collaboration

To establish KinetiSol technology manufacturing hub for DisperSol’s pipeline.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

DisperSol Technologies, a clinical-stage pharmaceutical company developing new treatments for oncology and rare diseases, and Catalent, a global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, have entered a manufacturing collaboration to accelerate the development of multiple DisperSol pharmaceutical products. The collaboration will see the installation of a commercial-scale KinetiS...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters